Research

Fascinating video documentary 'Princes of the Yen: Central Bank Truths' with Banking Expert and Oxford Professor Richard Werner. Werner believes that Central Bank creates...

A New Leader In The Drone Industry Emerges US Government Bans Chinese Drones Surprise Contract with Apple Co-Founder Leave Established Players Scrambling While Draganfly (DFLYF) is admittedly...

Electric Vehicle EV Engine ‘Retro-Fitting’ Company Nearing Commercialization Minerva Oil Field Deal Valued at $116 Million, Nearing Completion Principal Solar Incorporated is building a portfolio of...

Quantitative easing (QE) occurs when central banks, such as the U.S. Federal Reserve, create new money to buy government bonds or other securities. Some people...

Press Release: February 28, 2023 07:30 ET | Source: Society Pass Incorporated New York, NY, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Institutional Analyst Inc (“Institutional Analyst”) issues...

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $4.00 (from $1.65) while maintaining a Buy rating. The analyst commented,...

CLICK TO VIEW REPORT

The Bit Short: Inside Crypto’s Doomsday Machine Scary article on Tether/Bitcoin posted on Medium. This is the story of a Bitcoin trade — the most financially...

Mustang Bio Reports Full-Year 2018 Financial Results And Recent Corporate Highlights GlobeNewswire - Mon Mar 18, 6:29AM CDT Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused...

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the Biotech Stock...